Medical innovations: Their diffusion, adoption, and critical interrogation

Sociology Compass

Volumn 7, Issue 9, 2013, Pages 726-737

  Blume, Stuart S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883793077     PISSN: None     EISSN: 17519020     Source Type: Journal    
DOI: 10.1111/soc4.12062     Document Type: Article

References (76)

1. Abraham, J. 2008. 'Sociology of Pharmaceuticals Development and Regulation: A Realist Empirical Research Programme.' Sociology of Health & Illness 30(6): 869-85.
2. Abraham J. and C. Davis. 2007. 'Deficits, Expectations and Paradigms in British and American Drug Safety Assessments- Prising Open the Black Box of Regulatory Science.' Science Technology & Human Values 32(4): 399-431.
3. Abraham J. and T. Reed. 2002. 'Progress, Innovation and Regulatory Science in Drug Development.' Social Studies of Science 32(3): 337-69.
4. Altenstetter, C. (ed). 1981. Innovation in Health Policy and Service Delivery: A Cross-National Perspective. Cambridge Mass: Oelgeschlager, Gunn & Hain.
5. Anderson, J., F. Neary and J. V. Pickstone. 2007. Surgeons, Manufacturers and Patients. A Transatlantic History of Total Hip Replacement. London: Palgrave Macmillan.
6. Bell, E. and E. Racine. 2010. 'Deep Brain Stimulation, Ethics and Society.' The Journal of Clinical Ethics 21(2): 101-3.
7. Bijker, W. E. and J. Law (eds). 1992. Shaping Technology/Building Society. Studies in Sociotechnical Change. Cambridge, Mass: MIT Press.
8. Bijker, W. E., T. P. Hughes and T. Pinch (eds). 1987. The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology. Cambridge, Mass: MIT Press.
9. Blume, S. S. 1992. Insight and Industry. On the Dynamics of Technological Change in Medicine. Cambridge Mass: MIT Press.
10. Blume, S. S. 2010. The Artificial Ear. Cochlear Implantation and the Culture of Deafness. New Brunswick, NJ: Rutgers University Press.
11. Blume S. S. and J. Tump. 2010. 'Evidence and Policymaking: The Introduction of MMR Vaccine in the Netherlands.' Social Science & Medicine 71: 1049-55.
12. Bombard, Y., J. Abelson, D. Simeonov and F. P. Gauvin. 2011. 'Eliciting Ethical and Social Values in Health Technology Assessment. A Participatory Approach.' Social Science & Medicine 73(1): 135-44.
13. Brown P., S. Zavetovski, S. McCormick, et al. 2004. 'Embodied Health Movements: new Approaches to Social Movements in Health.' Sociology of Health & Illness 26(1): 50-80.
14. Clarke, A. E., L. Mamo, J. Fishman, J. Shim and J. R. Fosket. 2003. 'Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine.' American Sociological Review 68: 161-94.
15. Coleman, J. S., E. Katz and H. Menzel. 1966. Medical Innovation: A Diffusion Study. Indianapolis: Bobbs-Merill.
16. Conrad, P. and V. Leiter. 2004. 'Medicalization, Markets and Consumers.' Journal of Health and Social Behavior 45(Extra Issue): 158-76.
17. Crossley, N. 2006. 'The Field of Psychiatric Contention in the UK, 1960-2000.' Social Science & Medicine 62: 552-63.
18. Davies, C. 2007. 'Grounding Governance in Dialogue? Discourse, Practice and the Potential for A new Public Sector Organizational Form in Britain.' Public Administration 85(1): 47-66.
19. Davies, S. E. 2008. 'Securitizing Infectious Disease.' International Affairs 84(2): 295-313.
20. Davis, C. and J. Abraham. 2011. 'A Comparative Analysis of Risk Management Strategies in European Union and United States Pharmaceutical Regulation.' Health Risk & Society 13(5): 413-31.
21. De Vries R. and T. Lemmens. 2006. 'The Social and Cultural Shaping of Medical Evidence: Case Studies from Pharmaceutical Research and Obstetric Science.' Social Science & Medicine 62: 2694-706.
22. DiMaggio, P. J. and W. W. Powell. 1983. 'The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields.' American Sociological Review 48: 147.
23. Epstein, S. 1996. Impure Science. AIDS, Activism and the Politics of Knowledge. Berkeley and London: California University Press.
24. Erickson-Davis, C. 2012. 'Ethical Concerns Regarding Commercialization of Deep Brain Stimulation for Obsessive Compulsive Disorder.' Bioethics 26(8): 440-6.
25. Faulkner, A. 1997. ''Strange bedfellows' in the Laboratory of the NHS? An Analysis of the New Science of Health Technology Assessment in the United Kingdom.' Pp. 183-207 in The Sociology of Medical Science and Technology, edited by M. A. Elston. Oxford: Blackwell.
26. Faulkner, A., I. Geesink, J. Kent and D. FitzPatrick. 2003. 'Human Tissue Engineered Products - Drugs or Devices?' British Medical Journal 326: 1159-60.
27. Foote, S. B. 1992. Managing the Medical Arms Race. Innovation and Public Policy in the Medical Device Industry. Berkeley and Oxford: University of California Press.
28. Fox, R. C. 1973. Experiment Perilous, 2nd edition. Philadelphia: University of Pennsylvania Press.
29. Gagnon M.-P., M. Desmartis, D. Lepage-Savary, et al. 2011. 'Introducing Patients' and the Public's Perspectives to Health Technology Assessment: A Systematic Review of International Experiences.' International Journal of Technology Assessment in Health Care 27(1): 31-42.
30. Greer, A. C. 1984. 'Medical Technology and Professional Dominance Theory.' Social Science & Medicine 18: 809.
31. Haas M., T. Ashton, K. Blum et al. 2009. 'Drugs, Sex, Money and Power: An HPV Vaccine Case Study.' Health Policy 92: 288-95.
32. Hogle, L. 2001. 'Chemoprevention for Healthy Women: Harbinger of Things to Come?' Health 5(3): 311-33.
33. Hollingsworth J. R., J. Hage and R. A. Hanneman. 1990. State Intervention in Medical Care. Consequences for Britain, Sweden and the United States, 1890-1970. Ithaca and London: Cornell University Press.
34. Jeffrey, K. 2001. Machines in Our Hearts. The Cardiac Pacemaker, the Implantable Defibrillator, and American Health Care. Baltimore and London: Johns Hopkins University Press.
35. Knaapen, L., H. Cazaneuve, A. Cambrosio, P. Castel and B. Fervers. 2010. 'Pragmatic Evidence and Textual Arrangements: A Case Study of French Clinical Cancer Guidelines.' Social Science & Medicine 71: 685-92.
36. Lakoff, A. 2004. 'The Anxieties of Globalization: Antidepressant Sales and Economic Crisis in Argentina.' Social Studies of Science 34(2): 247-69.
37. Lambert, H. 2006. 'Accounting for EBM: Notions of Evidence in Medicine.' Social Science & Medicine 62: 2633-45.
38. Landsman G. H. 2006. 'What Evidence, Whose Evidence? Physical Therapy in New York State's Clinical Practice Guideline and in the Lives of Mothers of Disabled Children.' Social Science & Medicine 62: 2670-80.
39. Lehoux, P. and S. Blume. 2000. 'Technology Assessment and the Sociopolitics of Health Technologies.' Journal of Health Politics, Policy and Law 25(6): 1083-120.
40. Lehoux, P., G. Daudelin, O. Demers-Payette and A. Boivin. 2009. 'Fostering Deliberations About Health Innovation. What Do We Want to Know from Publics?' Social Science & Medicine 68(11): 2002-9.
41. Lehoux P., J. L. Denis, S. Tailliez and M. Hivon. 2005. 'Dissemination of Health Technology Assessments. Identifying the Visions Guiding an Evolving Policy Innovation in Canada.' Journal of Health Policy Politics and Law 30(4): 603-41.
42. Madhavi, Y. 2003. 'Manufacture of Consent? Hepatitis B Vaccination.' Economic and Political Weekly 38(24): 2417-24.
43. May, C. 2006. 'Mobilising Modern Facts: Health Technology Assessment and the Politics of Evidence.' Sociology of Health & Illness 28(5): 513-32.
44. May C., M. Mort, T. Williams, F. Mair and L. Gask. 2003. 'Health Technology Assessment in its Local Contexts: Studies of Telehealthcare.' Social Science & Medicine 57(4): 697-710.
45. McKinlay, J. B. 1981. 'From 'Promising Report' to 'Standard Procedure': Seven Stages in the Career of a Medical Innovation.' Millbank Memorial Fund Quarterly 59: 374.
46. Milewa, T. 2006. 'Health Technology Adoption and the Politics of Governance in the UK.' Social Science & Medicine 63(12): 3102-12.
47. Mol, A. 1998. 'Missing Links, Making Links. The Performance of Some Atherosclerosis.' in Differences in Medicine. Unravelling Practices, Techniques and Bodies, edited by M. Berg and A. Mol. Durham NC: Duke University Press.
48. Mol, A. 2002. The Body Multiple. Ontology in Medical Practice. Durham NC: Duke University Press.
49. Munira S. L. and S. A. Fritzen. 2007. 'What Influences Government Adoption of Vaccines in Developing Countries? A Policy Process Analysis.' Social Science & Medicine 65: 1751-64.
50. Office of Technology Assessment. 1976. Development of Medical Technology. Opportunities for Assessment. Washington DC: US Congress.
51. Office of Technology Assessment. 1978. Policy Implications of the Computed Tomography (CT) Scanner. Washington DC: US Congress.
52. Parthasarathy, S. 2007. Building Genetic Medicine. Breast Cancer, Technology, and the Comparative Politics of Health Care. Cambridge and London: MIT Press.
53. Petryna, A. 2005. 'Ethical Variability: Drug Development and Globalizing Clinical Trials.' American Ethnologist 32(2): 183-97.
54. Pope, C. 2003. 'Resisting Evidence: The Study of Evidence-Based Medicine as a Contemporary Social Movement.' Health 7(3): 267-82.
55. Porter, T. M. 1995. Trust in Numbers. The Pursuit of Objectivity in Science and Public Life. Princeton NJ: Princeton University Press.
56. Press, N. A. C. H. Browner. 1997. 'Why Women Say Yes to Prenatal Diagnosis.' Social Science & Medicine 45: 979-89.
57. Rabeharisoa, V. 2006. 'From Representation to Mediation: The Shaping of Collective Mobilization on Muscular Dystrophy in France.' Social Science & Medicine 62: 564-76.
58. Rabeharisoa V.and M. Callon. 2002. 'The Involvement of patients' Associations in Research.' International Social Science Journal 54: 57-65.
59. Rabinow, P. 1996. 'Artificiality and Enlightenment: From Sociobiology to Biosociality.' Pp. 91-111 in Essays on the Anthropology of Reason, edited by P. Rabinow. Princeton NJ: Princeton University Press.
60. Rapp, R. 2000. Testing Women, Testing the Fetus. London and New York: Routledge.
61. Remennick, L. 2006. 'The Quest for the Perfect Baby: why do Israeli Women Seek Prenatal Genetic Testing?' Sociology of Health & Illness 28(1): 21-53.
62. Roberts, E. B., R. I. Levy, S. N. Finkelstein, J. Moskowitz and E. J. Sondik (eds). 1981. Biomedical Innovation. Cambridge Mass: MIT Press.
63. Rogers E. M. 1962. Diffusion of Innovations. Glencoe: Free Press.
64. Rothman D. 1997. Beginnings Count. The Technological Imperative in American Health Care. New York and Oxford: Oxford University Press.
65. Russell, L. B. 1979. Technology in Hospital. Washington DC: the Brookings Institution.
66. Sathyamala C., O. Mittal, R. Dasgputa and R. Priya. 2005. 'Polio Eradication Initiative in India: Deconstructing the GPEI' International Journal of Health Services 35: 361-83.
67. Scott, A. and R. DuPlessis. 2008. 'Redefining a Technology: Public and Private Genetic Testing in Aotearoa, New Zealand.' Sociology of Health & Illness 30(3): 364-79.
68. Shakespeare, T. 1999. ''Losing the Plot?' Medical and Activist Discourses of Contemporary Genetics and Disability.' Sociology of Health & Illness 21(5): 669-88.
69. Sleeboom-Faulkner, M. E. 2011. 'Genetic Testing, Governance, and the Family in the People's Republic of China.' Social Science & Medicine 72: 1802-9.
70. Spielmans G. I. and P. I. Parry. 2010. 'From Evidence-Based Medicine to Marketing-Based Medicine: Evidence from Internal Industry Documents.' Bioethical Inquiry 7: 13-29.
71. Timmermans, S. and M. Berg. 2003. 'The Practice of Medical Technology.' Sociology of Health & Illness 25: 97-114.
72. Van den Bulte C. and G. L. Lilien. 2001. 'Medical Innovation Revisited: Social Contagion Versus Marketing Effort.' The American Journal of Sociology 106(5): 1409-35.
73. Vassy, C. 2006. 'From a Genetic Innovation to Mass Health Programmes: The Diffusion of Down's Syndrome Prenatal Screening and Diagnostic Techniques in France.' Social Science & Medicine 63: 2041-51.
74. Wagner, J. L. and M. Zubkoff. 1982. 'Medical Technology and Hospital Costs' Pp. 161-87 in Issues in Hospital Administration. Milbank Reader 9, edited by J. B. McKinlay. Cambridge and London: MIT Press.
75. Webster, A. (ed.). 2006. New Technology in Health Care. Challenge, Change and Innovation. London: Palgrave Macmillan.
76. Weisz, G., A. Cambrosio, P. Keating, et al. 2007. 'The Emergence of Clinical Practice Guidelines.' Milbank Memorial Quarterly 85(4): 691-727.